Divya Iyer
Senior Vice President and Head of Revenue for Pharma Direct, GoodRx
Divya Iyer is listed as Senior Vice President and Head of Revenue for Pharma Direct, GoodRx. Divya is scheduled to speak at World Evidence, Pricing and Access Congress USA on 15 September 2027.
Compiled from published conference agendas; not yet confirmed by Divya. Is this you? Claim this profile.
About
Divya Iyer is the Senior Vice President, Head of Revenue, Pharma Direct at GoodRx, where she oversees the teams responsible for building, scaling, and sustaining pharmaceutical manufacturer partnerships that help patients access their medications more affordably and with less friction. Prior to this role, Divya served as Senior Vice President, Go-To-Market Strategy, where she helped shape GoodRx’s approach to pharmaceutical partnerships and strengthen its position as a trusted commercialization partner for manufacturers. Under Divya’s leadership, GoodRx has collaborated with major pharmaceutical companies to improve patient access, including by introducing some of the lowest available self-pay prices for widely used therapies, while driving meaningful increases in filled prescriptions. Previously, Divya held senior roles at McKesson, where she transformed the company’s biopharma strategy and launched a new oncology data and insights business. She also served as a management consultant
Upcoming
World Evidence, Pricing and Access Congress USA 14 September 2027 – 15 September 2027
- Keynote Opening Panel: A Vision for Transparent, Value-Aligned Launch Pricing in 2027 and Beyond Speaker · 15 September 2027
- The Direct-To -Consumer Model: The New Commercial Architecture? Speaker · 15 September 2027
Spoke alongside
People who have shared a session with Divya at events on B2DB.
- Ipek Ozer Stillman Head, Global Health Economics, Payer Value & Patient Access · Takeda 1 shared session
- Charles Makin Head of RWE · Boehringer Ingelheim 1 shared session
- Ellie Adair Chief Operating Officer · ICER 1 shared session
- Sean Dickson Senior Vice President, Pharmaceutical Policy and Strategy · AHIP 1 shared session